Simultaneous determination of cytosine arabinoside and its metabolite, uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection

Biomedical Chromatography

Volumn 27, Issue 7, 2013, Pages 818-820

  Uchiyama, Masanobu ^a   Takamatsu, Yasushi ^a   Ogata, Kentaro ^a   Matsumoto, Taichi ^b   Jimi, Shiro ^b   Tamura, Kazuo ^a   Hara, Shuuji ^b  

^a FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Cytosine arabinoside; HILIC; Human plasma; Pharmacokinetics; Uracil arabinoside

Indexed keywords

AROMATIC COMPOUNDS; COLUMN CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; PATIENT MONITORING; PATIENT TREATMENT; PLASMA (HUMAN);

CYTOSINE ARABINOSIDE; HIGH DOSE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HILIC; HUMAN PLASMAS; HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHIES; PLASMA CONCENTRATION; SIMULTANEOUS DETERMINATIONS; URACIL ARABINOSIDE; UV DETECTION;

METABOLITES;

CYTARABINE; MITOXANTRONE; URACIL ARABINOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD LEVEL; CASE REPORT; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG MEGADOSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROPHILIC INTERACTION CHROMATOGRAPHY; KIDNEY FAILURE; MALE; ULTRAVIOLET RADIATION;

ARA;

EID: 84878990087     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2876     Document Type: Article

References (9)

1. Burk M, Volmer M, Fartash K and Schneider W. Ion-pair liquid chromatography of cytarabine and uracil-arabinoside in human plasma. Arzneimittel Forschung -Drug Research 1995; 45: 616-619.
2. Camiener GW. Studies of the enzymatic deamination of ara-cytidine. V. Inhibition in vitro and in vivo by tetrahydrouridine and other reduced pyrimidine nucleosides. Biochemical Pharmacology 1968; 17: 1981-1991.
3. Gouy M-H, Fabre H, Blanchin MD, Peyrotters S, Périgaud C and Lefebvre I. Quantification of 5′-monophosphate cytosine arabinoside (Ara-CMP) in cell extracts using liquid chromatography-electrospray mass spectrometry. Analytica Chimica Acta 2006; 566: 178-184.
4. Kovalova L, McArdell C and Hollender J. Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry. Journal of Chromatography. A 2009; 1216: 1100-1108.
5. Krogh-Madsen M, Hansen SH and Honoré PH. Simultaneous determination of cytosine arabinoside, daunorubicin and etoposide in human plasma. Journal of Chromatography B 2010; 878: 1967-1972.
6. Radeski D, Cull GM, Cain M, Hackett LP and Ilett KF. Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure. Cancer Chemotherapy and Pharmacology 2011; 67: 765-768.
7. Riccardi A, Servidei T, Lasorella A and Riccardi R. High-performance liquid chromatographic assay for cytosine arabinoside and uracil arabinoside in cerebrospinal fluid and plasma. Journal of Chromatography 1989; 497: 302-307.
8. van Nuijs ALN, Tarcomnicu I and Covaci A. Application of hydrophilic interaction chromatography for the analysis of polar contaminants in food and environmental samples. Journal of Chromatography. A 2011; 1218: 5964-5974.
9. Wermeling JR, Pruemer JM, Hassan FM, Warner A and Pesce AJ. Liquid-chromatographic monitoring of cytosine arabinoside and its metabolite, uracil arabinoside, in serum. Clinical Chemistry 1989; 35: 1011-1015.